The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer

Advances in Protein Chemistry and Structural Biology

Volumn 101, Issue , 2015, Pages 1-26

  Karaki, Sara ^a,b,c   Andrieu, Claudia ^a,b,c   Ziouziou, Hajer ^a,b,c   Rocchi, Palma ^a,b,c  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Cancer; eIF4E; Therapeutic target

Indexed keywords

INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN 1; INITIATION FACTOR 4G; MESSENGER RNA; POLYADENYLIC ACID;

HUMAN; NEOPLASM; NONHUMAN; NUCLEAR EXPORT SIGNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RNA TRANSLATION; TRANSLATION INITIATION; UBIQUITINATION; BIOSYNTHESIS; CHEMISTRY; GENETIC TRANSCRIPTION; GENETICS; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION;

EUKARYOTIC INITIATION FACTOR-4E; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; PROTEIN CONFORMATION; RNA, MESSENGER; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC;

EID: 84960503418     PISSN: 18761623     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.apcsb.2015.09.001     Document Type: Chapter

References (125)

1. A. Amiri, and et al. An isoform of eIF4E is a component of germ granules and is required for spermatogenesis in C. elegans Development 128 20 2001 3899 3912
2. C. Andrieu, and et al. Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E Oncogene 29 13 2010 1883 1896
3. G. Armengol, and et al. 4E-binding protein 1: A key molecular "funnel factor" in human cancer with clinical implications Cancer Research 67 16 2007 7551 7555
4. S. Assouline, and et al. Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): A proof-of-principle clinical trial with ribavirin Blood 114 2 2009 257 260
5. S. Avdulov, and et al. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells Cancer Cell 5 6 2004 553 563
6. S. Banerjee, and et al. Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cells Journal of Virology 76 12 2002 5937 5948
7. V. Baylot, and et al. OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer Cell Death and Disease 2 2011 e221
8. H.J. Berkel, and et al. Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon Cancer Epidemiology, Biomarkers & Prevention 10 6 2001 663 666
9. A. Bianchini, and et al. Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells Carcinogenesis 29 12 2008 2279 2288
10. S.P. Blagden, and A.E. Willis The biological and therapeutic relevance of mRNA translation in cancer Nature Reviews. Clinical Oncology 8 5 2011 280 291
11. K.L. Borden, and B. Culjkovic-Kraljacic Ribavirin as an anti-cancer therapy: Acute myeloid leukemia and beyond? Leukemia & Lymphoma 51 10 2010 1805 1815
12. C.J. Brown, and et al. Crystallographic and mass spectrometric characterisation of eIF4E with N7-alkylated cap derivatives Journal of Molecular Biology 372 1 2007 7 15
13. E.J. Campbell Dwyer, and et al. The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner Journal of Virology 74 7 2000 3293 3300
14. R. Cencic, and et al. Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F Proceedings of the National Academy of Sciences of the United States of America 108 3 2011 1046 1051
15. R. Cencic, and et al. Blocking eIF4E-eIF4G interaction as a strategy to impair coronavirus replication Journal of Virology 85 13 2011 6381 6389
16. Y. Chaudhry, and et al. Caliciviruses differ in their functional requirements for eIF4F components Journal of Biological Chemistry 281 35 2006 25315 25325
17. A.Y. Choo, and et al. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation Proceedings of the National Academy of Sciences of the United States of America 105 45 2008 17414 17419
18. N. Cohen, and et al. PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA The EMBO Journal 20 16 2001 4547 4559
19. L.J. Coleman, and et al. Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity British Journal of Cancer 100 9 2009 1393 1399
20. J.P. Crew, and et al. Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression British Journal of Cancer 82 1 2000 161 166
21. R. Cuesta, Q. Xi, and R.J. Schneider Adenovirus-specific translation by displacement of kinase Mnk1 from cap-initiation complex eIF4F The EMBO Journal 19 13 2000 3465 3474
22. B. Culjkovic, I. Topisirovic, and K.L. Borden Controlling gene expression through RNA regulons: The role of the eukaryotic translation initiation factor eIF4E Cell Cycle 6 1 2007 65 69
23. B. Culjkovic, and et al. eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3′UTR The Journal of Cell Biology 169 2 2005 245 256
24. R.V. Davuluri, and et al. CART classification of human 5′ UTR sequences Genome Research 10 11 2000 1807 1816
25. A. De Benedetti, and J.R. Graff eIF-4E expression and its role in malignancies and metastases Oncogene 23 18 2004 3189 3199
26. R.J. DeFatta, Y. Li, and A. De Benedetti Selective killing of cancer cells based on translational control of a suicide gene Cancer Gene Therapy 9 7 2002 573 578
27. R.J. DeFatta, C.O. Nathan, and A. De Benedetti Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line Laryngoscope 110 6 2000 928 933
28. T.D. Dinkova, and et al. Translation of a small subset of Caenorhabditis elegans mRNAs is dependent on a specific eukaryotic translation initiation factor 4E isoform Molecular and Cellular Biology 25 1 2005 100 113
29. K. Dong, and et al. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells Breast Cancer Research and Treatment 113 3 2009 443 456
30. J. Dostie, F. Lejbkowicz, and N. Sonenberg Nuclear eukaryotic initiation factor 4E (eIF4E) colocalizes with splicing factors in speckles The Journal of Cell Biology 148 2 2000 239 247
31. J. Dostie, and et al. A novel shuttling protein, 4E-T, mediates the nuclear import of the mRNA 5′ cap-binding protein, eIF4E The EMBO Journal 19 12 2000 3142 3156
32. T.W. Dreher, and W.A. Miller Translational control in positive strand RNA plant viruses Virology 344 1 2006 185 197
33. A.V. Evsikov, and C. Marin de Evsikova Evolutionary origin and phylogenetic analysis of the novel oocyte-specific eukaryotic translation initiation factor 4E in Tetrapoda Development Genes and Evolution 219 2 2009 111 118
34. S. Fan, and et al. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation Neoplasia 12 4 2010 346 356
35. M.E. Feldman, and et al. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2 PLoS Biology 7 2 2009 e38
36. L. Furic, and et al. eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression Proceedings of the National Academy of Sciences of the United States of America 107 32 2010 14134 14139
37. J.M. Garcia-Martinez, and et al. Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR) Biochemical Journal 421 1 2009 29 42
38. P. Ghosh, and et al. Synthesis and evaluation of potential inhibitors of eIF4E cap binding to 7-methyl GTP Bioorganic & Medicinal Chemistry Letters 15 8 2005 2177 2180
39. B. Ghosh, and et al. Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation ACS Chemical Biology 4 5 2009 367 377
40. A.C. Gingras, B. Raught, and N. Sonenberg Regulation of translation initiation by FRAP/mTOR Genes and Development 15 7 2001 807 826
41. A.C. Gingras, B. Raught, and N. Sonenberg mTOR signaling to translation Current Topics in Microbiology and Immunology 279 2004 169 197
42. I. Goodfellow, and et al. Calicivirus translation initiation requires an interaction between VPg and eIF 4 E EMBO Reports 6 10 2005 968 972
43. J.R. Graff, and et al. Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity The Journal of Clinical Investigation 117 9 2007 2638 2648
44. J.R. Graff, and et al. Targeting the eukaryotic translation initiation factor 4E for cancer therapy Cancer Research 68 3 2008 631 634
45. J.R. Graff, and et al. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival Cancer Research 69 9 2009 3866 3873
46. J.D. Gross, and et al. Ribosome loading onto the mRNA cap is driven by conformational coupling between eIF4G and eIF4E Cell 115 6 2003 739 750
47. K.J. Heesom, and et al. Cell cycle-dependent phosphorylation of the translational repressor eIF-4E binding protein-1 (4E-BP1) Current Biology 11 17 2001 1374 1379
48. T.P. Herbert, and et al. Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E Current Biology 10 13 2000 793 796
49. G. Hernandez, and P. Vazquez-Pianzola Functional diversity of the eukaryotic translation initiation factors belonging to eIF4 families Mechanisms of Development 122 7-8 2005 865 876
50. D.J. Hiller, and et al. Predictive value of eIF4E reduction after neoadjuvant therapy in breast cancer The Journal of Surgical Research 156 2 2009 265 269
51. N. Holm, and et al. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer Annals of Surgical Oncology 15 11 2008 3207 3215
52. A.C. Hsieh, and et al. Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E Cancer Cell 17 3 2010 249 261
53. F.J. Iborra, D.A. Jackson, and P.R. Cook Coupled transcription and translation within nuclei of mammalian cells Science 293 5532 2001 1139 1142
54. Y. Jia, and et al. Cap-dependent translation initiation factor eIF4E: An emerging anticancer drug target Medicinal Research Reviews 32 4 2012 786 814
55. B. Joshi, A. Cameron, and R. Jagus Characterization of mammalian eIF4E-family members European Journal of Biochemistry 271 11 2004 2189 2203
56. B. Joshi, and et al. Phylogenetic analysis of eIF4E-family members BMC Evolutionary Biology 5 2005 48
57. M.Y. Jung, L. Lorenz, and J.D. Richter Translational control by neuroguidin, a eukaryotic initiation factor 4E and CPEB binding protein Molecular and Cellular Biology 26 11 2006 4277 4287
58. A. Kentsis, and et al. The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E Journal of Molecular Biology 312 4 2001 609 623
59. A. Kentsis, and et al. Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap Proceedings of the National Academy of Sciences of the United States of America 101 52 2004 18105 18110
60. A. Kentsis, and et al. Further evidence that ribavirin interacts with eIF4E RNA 11 12 2005 1762 1766
61. S.R. Kimball Regulation of translation initiation by amino acids in eukaryotic cells Progress in Molecular and Subcellular Biology 26 2001 155 184
62. B.W. Konicek, and et al. Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases Cancer Research 71 5 2011 1849 1857
63. J. Kowalska, and et al. Phosphorothioate analogs of m7GTP are enzymatically stable inhibitors of cap-dependent translation Bioorganic & Medicinal Chemistry Letters 19 7 2009 1921 1925
64. M. Kozak Pushing the limits of the scanning mechanism for initiation of translation Gene 299 1-2 2002 1 34
65. H.K. Lai, and K.L. Borden The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA Oncogene 19 13 2000 1623 1634
66. S.K. Lee, and et al. Translation initiation factor 4E (eIF4E) is regulated by cell death inhibitor, Diap1 Molecules and Cells 24 3 2007 445 451
67. Y. Li, and et al. A translationally regulated Tousled kinase phosphorylates histone H3 and confers radioresistance when overexpressed Oncogene 20 6 2001 726 738
68. B.D. Li, and et al. Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome Annals of Surgery 235 5 2002 732 738 discussion 738-739
69. S. Li, and et al. Translation factor eIF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c release Journal of Biological Chemistry 278 5 2003 3015 3022
70. S. Li, and et al. Translation initiation factor 4E blocks endoplasmic reticulum-mediated apoptosis Journal of Biological Chemistry 279 20 2004 21312 21317
71. M. Lynch, and et al. hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation Molecular and Cellular Biology 25 15 2005 6436 6453
72. Y. Mamane, and et al. eIF4E - From translation to transformation Oncogene 23 18 2004 3172 3179
73. J. Matthews-Greer, and et al. eIF4E as a marker for cervical neoplasia Applied Immunohistochemistry & Molecular Morphology 13 4 2005 367 370
74. N. Minshall, and et al. CPEB interacts with an ovary-specific eIF4E and 4E-T in early Xenopus oocytes Journal of Biological Chemistry 282 52 2007 37389 37401
75. N.J. Moerke, and et al. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G Cell 128 2 2007 257 267
76. A.F. Monzingo, and et al. The structure of eukaryotic translation initiation factor-4E from wheat reveals a novel disulfide bond Plant Physiology 143 4 2007 1504 1518
77. T. Murata, and K. Shimotohno Ubiquitination and proteasome-dependent degradation of human eukaryotic translation initiation factor 4E Journal of Biological Chemistry 281 30 2006 20788 20800
78. A. Nakamura, K. Sato, and K. Hanyu-Nakamura Drosophila cup is an eIF4E binding protein that associates with Bruno and regulates oskar mRNA translation in oogenesis Developmental Cell 6 1 2004 69 78
79. C.O. Nathan, and et al. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway Clinical Cancer Research 10 17 2004 5820 5827
80. A. Niedzwiecka, E. Darzynkiewicz, and R. Stolarski Thermodynamics of mRNA 5′ cap binding by eukaryotic translation initiation factor eIF4E Biochemistry 43 42 2004 13305 13317
81. A. Niedzwiecka, and et al. Biophysical studies of eIF4E cap-binding protein: Recognition of mRNA 5′ cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins Journal of Molecular Biology 319 3 2002 615 635
82. D. Niessing, S. Blanke, and H. Jackle Bicoid associates with the 5′-cap-bound complex of caudal mRNA and represses translation Genes and Development 16 19 2002 2576 2582
83. P.H. O'Farrell Triggering the all-or-nothing switch into mitosis Trends in Cell Biology 11 12 2001 512 519
84. S. Othumpangat, M. Kashon, and P. Joseph Eukaryotic translation initiation factor 4E is a cellular target for toxicity and death due to exposure to cadmium chloride Journal of Biological Chemistry 280 26 2005 25162 25169
85. V.A. Polunovsky, and et al. Translational control of the antiapoptotic function of Ras Journal of Biological Chemistry 275 32 2000 24776 24780
86. D. Prevot, J.L. Darlix, and T. Ohlmann Conducting the initiation of protein synthesis: The role of eIF4G Biology of the Cell 95 3-4 2003 141 156
87. F.A. Quiocho, G. Hu, and P.D. Gershon Structural basis of mRNA cap recognition by proteins Current Opinion in Structural Biology 10 1 2000 78 86
88. T. Regad, and M.K. Chelbi-Alix Role and fate of PML nuclear bodies in response to interferon and viral infections Oncogene 20 49 2001 7274 7286
89. J.D. Richter, and N. Sonenberg Regulation of cap-dependent translation by eIF4E inhibitory proteins Nature 433 7025 2005 477 480
90. J. Robalino, and et al. Two zebrafish eIF4E family members are differentially expressed and functionally divergent Journal of Biological Chemistry 279 11 2004 10532 10541
91. G.W. Rogers Jr., A.A. Komar, and W.C. Merrick eIF4A: The godfather of the DEAD box helicases Progress in Nucleic Acid Research and Molecular Biology 72 2002 307 331
92. P. Rosettani, and et al. Structures of the human eIF4E homologous protein, h4EHP, in its m7GTP-bound and unliganded forms Journal of Molecular Biology 368 3 2007 691 705
93. D. Ruggero, and et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis Nature Medicine 10 5 2004 484 486
94. Z. Salehi, F. Mashayekhi, and F. Shahosseini Significance of eIF4E expression in skin squamous cell carcinoma Cell Biology International 31 11 2007 1400 1404
95. G.C. Scheper, and C.G. Proud Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation? European Journal of Biochemistry 269 22 2002 5350 5359
96. G.C. Scheper, and et al. The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells Molecular and Cellular Biology 21 3 2001 743 754
97. E.V. Schmidt The role of c-myc in regulation of translation initiation Oncogene 23 18 2004 3217 3221
98. J.S. Shenberger, and et al. Hyperoxia alters the expression and phosphorylation of multiple factors regulating translation initiation American Journal of Physiology. Lung Cellular and Molecular Physiology 288 3 2005 L442 L449
99. M. Shveygert, and et al. Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-activated protein kinase occurs through modulation of Mnk1-eIF4G interaction Molecular and Cellular Biology 30 21 2010 5160 5167
100. H.H. Sillje, and E.A. Nigg Identification of human Asf1 chromatin assembly factors as substrates of Tousled-like kinases Current Biology 11 13 2001 1068 1073
101. N. Sonenberg eIF4E, the mRNA cap-binding protein: From basic discovery to translational research Biochemistry and Cell Biology 86 2 2008 178 183
102. M. Stoneley, and A.E. Willis Cellular internal ribosome entry segments: Structures, trans-acting factors and regulation of gene expression Oncogene 23 18 2004 3200 3207
103. S. Strudwick, and K.L. Borden The emerging roles of translation factor eIF4E in the nucleus Differentiation 70 1 2002 10 22
104. P. Syntichaki, K. Troulinaki, and N. Tavernarakis eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans Nature 445 7130 2007 922 926
105. A. Tan, and et al. Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1 Oncogene 19 11 2000 1437 1447
106. K. Tan, and et al. Ribavirin targets eIF4E dependent Akt survival signaling Biochemical and Biophysical Research Communications 375 3 2008 341 345
107. S.C. Thumma, and R.A. Kratzke Translational control: A target for cancer therapy Cancer Letters 258 1 2007 1 8
108. K. Tomoo, and et al. Crystal structures of 7-methylguanosine 5′-triphosphate (m(7)GTP)- and P(1)-7-methylguanosine-P(3)-adenosine-5′,5′-triphosphate (m(7)GpppA)-bound human full-length eukaryotic initiation factor 4E: Biological importance of the C-terminal flexible region Biochemical Journal 362 Pt 3 2002 539 544
109. K. Tomoo, and et al. Structural features of human initiation factor 4E, studied by X-ray crystal analyses and molecular dynamics simulations Journal of Molecular Biology 328 2 2003 365 383
110. I. Topisirovic, and et al. The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth The EMBO Journal 22 3 2003 689 703
111. I. Topisirovic, and et al. Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis Molecular and Cellular Biology 23 24 2003 8992 9002
112. C. Tschopp, and et al. Phosphorylation of eIF-4E on Ser 209 in response to mitogenic and inflammatory stimuli is faithfully detected by specific antibodies Molecular Cell Biology Research Communications 3 4 2000 205 211
113. T. Ueda, and et al. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development Molecular and Cellular Biology 24 15 2004 6539 6549
114. K. Van Der Kelen, and et al. Translational control of eukaryotic gene expression Critical Reviews in Biochemistry and Molecular Biology 44 4 2009 143 168
115. L. Volpon, and et al. Cap-free structure of eIF4E suggests a basis for conformational regulation by its ligands The EMBO Journal 25 21 2006 5138 5149
116. L. Volpon, and et al. Structural characterization of the Z RING-eIF4E complex reveals a distinct mode of control for eIF4E Proceedings of the National Academy of Sciences of the United States of America 107 12 2010 5441 5446
117. T. von Der Haar, P.D. Ball, and J.E. McCarthy Stabilization of eukaryotic initiation factor 4E binding to the mRNA 5′-Cap by domains of eIF4G Journal of Biological Chemistry 275 39 2000 30551 30555
118. X. Wang, and et al. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins Molecular and Cellular Biology 25 7 2005 2558 2572
119. R. Wang, and et al. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma Lung Cancer 66 2 2009 237 244
120. H.G. Wendel, and et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy Nature 428 6980 2004 332 337
121. B. Westman, and et al. The antiviral drug ribavirin does not mimic the 7-methylguanosine moiety of the mRNA cap structure in vitro RNA 11 10 2005 1505 1513
122. Y. Yan, and et al. Ribavirin is not a functional mimic of the 7-methyl guanosine mRNA cap RNA 11 8 2005 1238 1244
123. S.X. Yang, and et al. Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray Oncology Reports 17 2 2007 281 287
124. K. Yu, and et al. Beyond rapalog therapy: Preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2 Cancer Research 70 2 2010 621 631
125. S.G. Zimmer, A. DeBenedetti, and J.R. Graff Translational control of malignancy: The mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis Anticancer Research 20 3A 2000 1343 1351